SpectRx/Abbott Labs
This article was originally published in The Gray Sheet
Executive Summary
Sale of an additional $2.5 mil. in convertible redeemable preferred stock to Abbott completes the purchase of a total of $5.3 mil. in convertible redeemable preferred stock as part of an agreement to jointly develop a continuous glucose monitor. An initial sale of $2.8 mil. in stock was announced late last year (1"The Gray Sheet" Dec. 20, p. 17)